IM Cannabis (NASDAQ:IMCC) Announces Quarterly Earnings Results

IM Cannabis (NASDAQ:IMCC) posted its quarterly earnings data on Monday. The company reported ($0.23) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.16, Zacks reports. IM Cannabis had a negative return on equity of 129.86% and a negative net margin of 25.55%. The company had revenue of $9.27 million for the quarter, compared to analyst estimates of $14.48 million.

IM Cannabis Trading Up 5.0 %

IMCC opened at $1.59 on Wednesday. IM Cannabis has a 1-year low of $1.50 and a 1-year high of $8.10. The stock has a market capitalization of $3.54 million, a PE ratio of -0.46 and a beta of 1.03. The company has a current ratio of 0.70, a quick ratio of 0.59 and a debt-to-equity ratio of 0.10. The firm has a 50-day moving average price of $2.02 and a two-hundred day moving average price of $2.26.

IM Cannabis Company Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.